Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Buy These 2 Stocks That Were Oversold Even Before the Market Selloff

Published 2019-05-17, 08:00 a/m
Updated 2019-05-17, 08:06 a/m
Buy These 2 Stocks That Were Oversold Even Before the Market Selloff
Buy These 2 Stocks That Were Oversold Even Before the Market Selloff

If the market continues the selloff that we are seeing recently, the list of “undervalued” and “oversold” stocks will grow, leaving investors with many choices, some of which may seem undervalued but, upon closer inspection, will prove not to be.

I would like to present two stocks that were undervalued even before the market selloff began and that, in fact, have been undervalued for a long time.

These are two stocks investors can look to today for value creation, limited downside, and big upside.

Enerplus (TSX:ERF)(NYSE:ERF) Enerplus is one of those stocks that has been consistently ignored despite the quality of its financials, its history of shareholder value creation, and its consistently strong cash position and cash generation, all of which imply that accelerated share repurchases and dividend increases are coming.

In its latest quarter, the first quarter on 2019, Enerplus continued its solid performance, posting a more than 4% production growth rate, a 4.5% increase in funds from operations, and a stellar balance sheet, with a net debt to funds flow ratio of a mere 0.5 times.

In the last three years, cash flow has grown at a CAGR of 17%, more than $300 million of free cash flow has been generated, and returns on capital have been impressive.

Oil prices remain above $60, and natural gas prices are showing signs of strength and hope for the future.

Despite all of this, the stock is down 11% since its April highs.

Nutrien (TSX:NTR)(NYSE:NTR) Nutrien is another name that has been undervalued for a while now.

Investors have an attractive entry point into shares of Nutrien at this time, as it is trading at an attractive price-to-earnings multiple of below 20 times 2020 expected consensus earnings, offers a dividend yield of 3.3%, and offers an increasing EBITDA and cash flow profile.

Nutrien stock is down almost 7% from April highs and continues to see downward pressure, despite the fact that synergies from the merger of Potash and Agrium are coming in higher than expected, free cash flow is growing rapidly, and cash flow generated from 2019 to 2021 is expected to be as high as $10 billion.

Investors can expect this cash flow profile to result in continued share buybacks and dividend increases, which can be expected to provide support for the stock.

Final thoughts These two oversold and undervalued stocks have long underperformed and disappointed shareholders. Going forward, we can expect them to be rewarded for their strong balance sheets and cash flow-generation capability. Add these oversold stocks today.

Fool contributor Karen Thomas has no position in any of the stocks mentioned. Nutrien is a recommendation of Stock Advisor Canada.

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2019

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.